1-15 of 469
Maintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
NutritionEdgeMaintaining Weight Loss: Early Evidence on Microbiome-Derived Supplementation
Marlene Mimi Maeusli, PhD.
Hallie Blevins, PhD
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
Diabetes DiscourseAddressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
John W. Ostrominski, MD, MPH
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Diabetes DiscourseEnhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
Laura Chiavaroli, PhD
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
Diabetes DiscourseInvestigating Beta Cell Dysfunction and Immune Activity in Early T1D
Edward Phelps, PhD
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Diabetes DiscourseInvestigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
Vira Kravets, PhD
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Diabetes DiscourseUnanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
Edward Phelps, PhD
- advertisement
Assessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
On the Frontlines of PsoriasisAssessing the Evidence for GLP-1 Receptor Agonists in Psoriatic Disease
Mary Leuchars, MD
Jeffrey Cohen, MD, MPH
The Potential Role of GLP-1s in Psoriatic Arthritis Management
Living RheumThe Potential Role of GLP-1s in Psoriatic Arthritis Management
Philip Mease, MD, MACR
SGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Living RheumSGLT2 Inhibitors Linked to Lower RA Risk Versus Sulfonylureas in T2D
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Updated AACE Guidance on Managing Dyslipidemia in T2D
Heart MattersUpdated AACE Guidance on Managing Dyslipidemia in T2D
Scott D. Isaacs, MD FACP, FACE
Complication-Centric Diabetes Care: Addressing Obesity and Cardiometabolic Risk
Heart MattersComplication-Centric Diabetes Care: Addressing Obesity and Cardiometabolic Risk
Scott D. Isaacs, MD FACP, FACE
- advertisement
Exploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Clinician's RoundtableExploring the Risk of Type 2 Diabetes Following SARS-CoV-2 Infection
Carolyn Bramante
Key CKD Updates from the 2026 NKF Meetings
Clinician's RoundtableKey CKD Updates from the 2026 NKF Meetings
Charles Turck, PharmD, BCPS, BCCCP
Matthew R. Weir, MD
Suneel Udani, MD
Contraceptive Counseling in the Era of GLP-1 Therapies
Advances in Women's HealthContraceptive Counseling in the Era of GLP-1 Therapies
Shelina Ramnarine, PhD
Halina Yee, MD